A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Clinical trial NCT07213609 · RECRUITING

Trial details

NCT number: NCT07213609
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms, Colorectal Neoplasms

Start date: 2025-10-20
Primary completion: 2028-09-28
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.